Healthtech Investors & VC Firms in China

223 firms in this list, with a median first check of $1.4M. 31 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
3H 3H Health Investment	88🔒	Shanghai	CN	Series A–Late Stage	—	+ Add to CRM
CH China Merchants Capital	88🔒	Shenzhen	CN	Growth–Late Stage	—	+ Add to CRM
CI CICC	88🔒	Beijing	CN	Growth–Late Stage	—	+ Add to CRM
GL GL Ventures	88🔒	Beijing	CN	Seed–Growth	—	+ Add to CRM
CO Co-Stone Capital	88🔒	Shenzhen	CN	Seed–Growth	—	+ Add to CRM
HA Haier HOPE / HCH innovation platform	88🔒	Qingdao	CN	Pre-Seed–Growth	—	+ Add to CRM
SA SAIF Partners China	88🔒	Beijing	CN	Seed–Growth	—	+ Add to CRM
SD SDIC Venture Capital / SDIC Fund Management	88🔒	Beijing	CN	Seed–Growth	—	+ Add to CRM
TA Tai Partners	88🔒	Shanghai	CN	Seed–Series B	—	+ Add to CRM
ZE Zero2IPO	88🔒	Beijing	CN	Seed–Late Stage	—	+ Add to CRM
NE New Enterprise Associates (NEA) MJSSAJAB72 people · Leads rounds	88🔒	Menlo Park	US	Seed–Late Stage	$200K – $40M	+ Add to CRM
F- F-Prime Capital DJAPBCCB110 people · Leads rounds	88🔒	Cambridge	US	Pre-Seed–Late Stage	$3M – $10M	+ Add to CRM
GO Gobi Partners TGAMCCCT74 people · Leads rounds	88🔒	Hong Kong	HK	Pre-Seed–Late Stage	$709K – $37M	+ Add to CRM
NO Novo Holdings ANALAEAS47 people	88🔒	Copenhagen	DK	Pre-Seed–Late Stage	$1.1M – $54M	+ Add to CRM
HO HongShan Capital Group NSEI于何46 people · Leads rounds	88🔒	Hong Kong	HK	Pre-Seed–Late Stage	$100K – $50M	+ Add to CRM
VU VU Venture Partners AKAZAGBG40 people · Leads rounds	88🔒	San Francisco	US	Seed–Series B	$200K – $1M	+ Add to CRM
AD Advent International RAAABTCE61 people · Leads rounds	88🔒	Boston	US	Series A–Late Stage	$1.1B	+ Add to CRM
SO SOSV SOSMAKAG30 people · Leads rounds	88🔒	New York	US	Pre-Seed–Series B	$30K – $550K	+ Add to CRM
AR Artesian JCJMMCAC39 people · Leads rounds	88🔒	Sydney	AU	Pre-Seed–Late Stage	$20M	+ Add to CRM
TE Tenaya Capital BBBMBPSG8 people	88🔒	Palo Alto	US	Series A–Late Stage	$5M – $10M	+ Add to CRM
CE Celesta Capital LTMMNBSV33 people · Leads rounds	88🔒	Menlo Park	US	Seed–Late Stage	$5M – $20M	+ Add to CRM
EI Eight Roads Ventures DHLCSBVB20 people	88🔒	Mumbai	IN	Seed–Late Stage	$5M – $30M	+ Add to CRM
AD Advantage Partners Inc. RFTSHNKB49 people	88🔒	Tokyo	JP	Growth–Late Stage	—	+ Add to CRM
VI Vivo Capital ACDXEGGA22 people · Leads rounds	88🔒	Palo Alto	US	Seed–Late Stage	$10M – $50M	+ Add to CRM

3H Health Investment

ShanghaiSeries A–Late Stage

China Merchants Capital

ShenzhenGrowth–Late Stage

CICC

BeijingGrowth–Late Stage

GL Ventures

BeijingSeed–Growth

Co-Stone Capital

ShenzhenSeed–Growth

Haier HOPE / HCH innovation platform

QingdaoPre-Seed–Growth

SAIF Partners China

BeijingSeed–Growth

SDIC Venture Capital / SDIC Fund Management

BeijingSeed–Growth

Tai Partners

ShanghaiSeed–Series B

Zero2IPO

BeijingSeed–Late Stage

New Enterprise Associates (NEA)

Menlo ParkSeed–Late Stage$200K – $40M

MJSSAJAB72 people

F-Prime Capital

CambridgePre-Seed–Late Stage$3M – $10M

DJAPBCCB110 people

Gobi Partners

Hong KongPre-Seed–Late Stage$709K – $37M

TGAMCCCT74 people

Novo Holdings

CopenhagenPre-Seed–Late Stage$1.1M – $54M

ANALAEAS47 people

HongShan Capital Group

Hong KongPre-Seed–Late Stage$100K – $50M

NSEI于何46 people

VU Venture Partners

San FranciscoSeed–Series B$200K – $1M

AKAZAGBG40 people

Advent International

BostonSeries A–Late Stage$1.1B

RAAABTCE61 people

SOSV

New YorkPre-Seed–Series B$30K – $550K

SOSMAKAG30 people

Artesian

SydneyPre-Seed–Late Stage$20M

JCJMMCAC39 people

Tenaya Capital

Palo AltoSeries A–Late Stage$5M – $10M

BBBMBPSG8 people

Celesta Capital

Menlo ParkSeed–Late Stage$5M – $20M

LTMMNBSV33 people

Eight Roads Ventures

MumbaiSeed–Late Stage$5M – $30M

DHLCSBVB20 people

Advantage Partners Inc.

TokyoGrowth–Late Stage

RFTSHNKB49 people

Vivo Capital

Palo AltoSeed–Late Stage$10M – $50M

ACDXEGGA22 people

Data sourced from public filings and firms' own websites — see our methodology.